Abstract: A display device includes: a first electrode and a second electrode spaced apart from each other; first and second light emitting elements between the first electrode and the second electrode; a first contact electrode contacting the first electrode and a first end portion of the first light emitting element; a second contact electrode contacting a second end portion of the first light emitting element; a third contact electrode contacting the second contact electrode and a first end portion of the second light emitting element and overlapping the first electrode; and a fourth contact electrode contacting a second end portion of the second light emitting element and overlapping the second electrode. The first contact electrode and the third contact electrode are on the same layer.

Abstract: Disclosed herein is an apparatus for imaging nano magnetic particles using a 3D array of small magnets. A field-free region generation apparatus includes a hexahedral housing having an opening formed in the first surface thereof such that a measurement head is inserted into a spacing area, a pair of rectangular-shaped magnets installed respectively on two surfaces facing each other, among four surfaces perpendicular to the first surface of the housing, and a pair of magnet arrays installed respectively on the first surface of the housing and on another surface facing the first surface, each of the magnet arrays including multiple small magnets arranged along the edge of the opening.

Abstract: Disclosed herein are a magnetic-field-generating coil system, an imaging system having the magnetic-field-generating coil system, and a method for operating the imaging system. The method for operating an imaging system includes generating multiple Linear Gradient Fields (LGFs) in respective axial directions by controlling coil currents, and acquiring MRI information or Magnetic Particle Imaging (MPI) information about an object while moving the multiple LGFs by varying the coil currents.

Abstract: A display device and a method of manufacturing the same are provided. A display device includes: a substrate including a plurality of pixels; a first electrode and a second electrode spaced apart from each other on the substrate; a light emitting element located between the first electrode and the second electrode; and a conductive pattern on the light emitting element. The light emitting element includes a first semiconductor layer, a second semiconductor layer, and an active layer between the first semiconductor layer and the second semiconductor layer, and the conductive pattern overlaps the active layer and does not overlap the first semiconductor layer or the second semiconductor layer.

Abstract: Disclosed herein is a nano-magnetic-particle-imaging apparatus, including a measurement head including excitation and detection coils and accommodating a sample bed for a sample including nano magnetic particles; a gradient magnetic field generation unit for generating a magnetic field having a strength equal to or greater than that of the saturation magnetic field of the nano magnetic particles in a spacing area between identical magnetic poles facing each other and forming a field-free region in a portion thereof; a first driving unit for linearly moving the sample bed; a second driving unit for rotating the gradient magnetic field generation unit in a plane; a third driving unit for linearly reciprocating the gradient magnetic field generation unit; and a control unit for applying a signal to the excitation coil, controlling the driving units, and imaging 3D distribution of the nano magnetic particles based on a detection signal output from the detection coil.

Abstract: Disclosed is an IgG Fc fragment useful as a drug carrier. A recombinant vector expressing the IgG Fc fragment, a transformant transformed with the recombinant vector, and a method of preparing an IgG Fc fragment are disclosed. When conjugated to a certain drug, the IgG Fc fragment improves the in vivo duration of action of the drug and minimizes the in vivo activity reduction of the drug.

Abstract: The present invention relates to a top nozzle and a nuclear reactor in which an in-core instrument, which is supposed to be inserted through a top head of a nuclear reactor, is inserted through a guide pin for an upper core plate. In a nuclear reactor including guide pins for aligning a top nozzle for a nuclear fuel assembly with an upper core plate of a nuclear reactor, a guide hole (210) is axially formed through the guide pins (200) and in-core instruments (10) are inserted through the guide holes (210).

Abstract: The present invention relates to a top nozzle and a nuclear reactor in which an in-core instrument, which is supposed to be inserted through a top head of a nuclear reactor, is inserted through a guide pin for an upper core plate. In a nuclear reactor including guide pins for aligning a top nozzle for a nuclear fuel assembly with an upper core plate of a nuclear reactor, a guide hole (210) is axially formed through the guide pins (200) and in-core instruments (10) are inserted through the guide holes (210).

Abstract: Disclosed herein are a magnetic-field-generating coil system, an imaging system having the magnetic-field-generating coil system, and a method for operating the imaging system. The method for operating an imaging system includes generating multiple Linear Gradient Fields (LGFs) in respective axial directions by controlling coil currents, and acquiring MRI information or Magnetic Particle Imaging (MPI) information about an object while moving the multiple LGFs by varying the coil currents.

Abstract: Disclosed are a composition for preventing or treating diabetes, disbesity or diabetic complications, containing an oxyntomodulin analog as an active ingredient and a method for treating diabetes, diabesity or diabetic complications, including administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog shows a greater activity to activate a GLP-1 receptor and a glucagon receptor, than native oxyntomodulin. The oxyntomodulin analog induces an expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in a body weight and appetite to improve insulin sensitivity and is useful in maintaining normal blood glucose levels.

Abstract: The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

Abstract: Disclosed is an IgG Fc fragment useful as a drug carrier. A recombinant vector expressing the IgG Fc fragment, a transformant transformed with the recombinant vector, and a method of preparing an IgG Fc fragment are disclosed. When conjugated to a certain drug, the IgG Fc fragment improves the in vivo duration of action of the drug and minimizes the in vivo activity reduction of the drug.

Abstract: The present invention relates to a lower end fitting for reducing flow resistance due to an in-core instrument in a nuclear fuel assembly, that is, a lower end fitting (100) having a plurality of flow holes for a nuclear fuel assembly, in which the flow holes (121) are formed under an assembly groove in which an instrumentation tube (131) for a nuclear fuel assembly is inserted, and at least two or more flow holes (121) are formed at a predetermined distance from the central axis (C) of the instrumentation tube (131).

Abstract: Disclosed is an IgG Fc fragment useful as a drug carrier. A recombinant vector expressing the IgG Fc fragment, a transformant transformed with the recombinant vector, and a method of preparing an IgG Fc fragment are disclosed. When conjugated to a certain drug, the IgG Fc fragment improves the in vivo duration of action of the drug and minimizes the in vivo activity reduction of the drug.

Abstract: Disclosed are a composition for preventing or treating diabetes, disbesity or diabetic complications, containing an oxyntomodulin analog as an active ingredient and a method for treating diabetes, diabesity or diabetic complications, including administering a pharmaceutically effective amount of an oxyntomodulin analog to a subject. The oxyntomodulin analog shows a greater activity to activate a GLP-1 receptor and a glucagon receptor, than native oxyntomodulin. The oxyntomodulin analog induces an expansion of beta-cells and increases insulin secretion, thereby reducing blood glucose levels that were increased due to a high-calorie and high-fat diet. The oxyntomodulin analog induces decreases in a body weight and appetite to improve insulin sensitivity and is useful in maintaining normal blood glucose levels.

Abstract: The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

Abstract: A combination of a top nozzle and a guide thimble of a nuclear fuel assembly and, more particularly, a structure for joining an inner-extension tube, the top nozzle and the guide thimble. When an inner-extension tube head, which is provided as a means for facilitating removal of the top nozzle of the nuclear fuel assembly from the guide thimble, is removed from an inner-extension tube body to separate the top nozzle from the nuclear fuel assembly, the inner-extension tube body is prevented from undesirably rotating, so that the guide thimble and the inner-extension tube body can maintain the joined state.

Abstract: The present invention relates to a composition for preventing or treating hyperlipidemia, fatty liver disease or arteriosclerosis, comprising an oxyntomodulin derivative as an active ingredient. The oxyntomodulin derivative has a high ability to activate GLP-1 receptor and glucagon receptor compared to native oxyntomodulin and has the effects of reducing the blood total cholesterol, low-density cholesterol and triglyceride levels that were increased by high-fat diet, and increasing high-density cholesterol levels and the high-density cholesterol/low-density cholesterol ratio. Thus, the oxyntomodulin derivative can be effectively used for the treatment of hyperlipidemia and related diseases.

Abstract: A method of guiding a gesture in an electronic device is provided. The method includes sensing a gesture input via an input tool on a screen; predicting a first proceeding direction of the gesture based on information about the gesture; determining a first guide object corresponding to the predicted first proceeding direction; predicting a second proceeding direction of the gesture based on information about a changed gesture when a proceeding direction of the gesture is changed; and determining a second guide object different from the first guide object and corresponding to the predicted second proceeding direction.